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Heart diseases are an important cause of morbidity and mortality in industrialized countries. Dilated
cardiomyopathy (DCM), one of the most common heart diseases, may be the consequence of infection-
associated myocardits. Coxsackievirus B3 (CVB3) can be frequently detected in the inﬂamed heart
muscle. CVB3-induced acute myocarditis is most likely the consequence of direct virus-induced
myocyte damage, whereas chronic CVB3 infection-associated heart disease is dominated by its
immunopathological sequelae. Bona ﬁde autoimmunity, for example, directed against cardiac myosin,
may favor chronic destructive immune damage in the heart muscle and thereby promote the
development of DCM. The immunopathogenesis of myocarditis and subsequent DCM induced either
by pathogens or autoantigens can be investigated in well-established animal models. In this article, we
review recent studies on the role of viruses, with particular emphasis on CVB3, and different
immunological effector mechanisms in initiation and progression of myocarditis.
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INTRODUCTION
Infections with viruses, protozoan intracellular parasites
or bacteria may be associated with myocarditis (Brown
and O’Connell, 1995; Bowles et al., 2003). Even
vaccination efforts, such as recent vaccinia virus programs
are a potential cause of cardiac adverse events (Murphy
et al., 2003). The most commonly known viral infectant of
the heart are the Coxsackie B group viruses (CVB) in the
Picornaviridae family. CVB3 RNA, for example, can be
detected in the heart muscle of 40–50% of patients with
dilated cardiomyopathy (DCM) (Fenoglio et al., 1983;
James, 1983; Dec et al., 1985; Keating and Sanguinetti,
1996) and serological studies have shown a strong
correlation between the presence of CVB3-speciﬁc
antibodies and myocarditis (El-Hagrassy et al., 1980).
Furthermore, CVB3 infection has been proposed to be the
major cause of pediatric myocarditis (Kaplan et al., 1983).
Humans are the natural host for CVB3. The ability of
this virus to infect mice and the susceptibility of speciﬁc
mouse strains for CVB3-induced myocarditis provides a
model system for the investigation of CVB3-induced
immunopathological heart disease. Depending on the
genetic background, the experimental disease in mice can
be monophasic (acute myocarditis) or biphasic (acute
myocarditis and subsequent low-grade inﬂammation).
In the second phase of the biphasic myocarditis, infectious
virus is usually no longer detectable and ongoing
inﬂammation leads to heart muscle ﬁbrosis and ventricular
dilation. Mouse strains showing a biphasic disease
progression are thus well-suited to study the shift from
a viral infection with local tissue destruction to the
induction of chronic immune responses to autoantigens
(Kawai, 1999; Feldman et al., 2000; Cunningham, 2001).
ACUTE CVB3-INDUCED MYOCARDITIS
In situ hybridization and gene ampliﬁcation studies
support the notion that viral infection and persistence of
viral RNA may lead to direct cytopathic damage of
cardiomyocytes (Kandolf et al., 1993; Klingel and
Kandolf, 1993; Saraste et al., 2003). The high cyto-
pathogenic potential of CVB3 can be demonstrated in
vitro by rapid lysis of cardiomyocytes (Herzum et al.,
1994), and in vivo in SCID mice lacking B- and T-cells,
where the uncontrolled replication of CVB3 leads to
severely enhanced myocardial damage (Chow et al.,
1992). Cell death occurring in the early phase of the
infection may be a trigger for the subsequent inﬂamma-
tion. The early inﬁltrate in hearts of CVB3 infected mice
consists of macrophages and T cells and a large proportion
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(Godeny and Gauntt, 1987a; Henke et al., 1995). In CVB
infected humans, macrophages and T cells are found
among the inﬁltrating cells and a predominance of the
Vb7 TCR was described (Luppi et al., 2003).
An early and efﬁcient immune response is essential for
the protection against cytopathic viruses (Zinkernagel,
1996). However, the immune response against CVB3 may
be a double-edged sword. For example, depletion of abT
cells from CVB3-infected mice leads to a marked
reduction in myocardial damage, despite comparable
virus titers to control animals (Kishimoto and Abelmann,
1989). Likewise, gdT cells may contribute to immuno-
pathological damage of cardiomyocytes (Huber, 2000;
Huber et al., 2001). A recent study by Huber and
colleagues shows that CD1d-restricted gdT cells signiﬁ-
cantly promote the initial myocardial damage, but are
not essential for viral clearance (Huber et al., 2003).
These results emphasize that it is most likely the quality
of the initial anti-CVB3 response that sets the stage for
the chronic immunopathological damage of the heart
muscle.
Innate Immune Responses in Early Virus-induced
Myocarditis
Natural killer (NK) cells are able to inhibit the replication
of CVB3 as shown by the fact that NK cell depletion leads
to increased viral titers and more severe myocarditis
(Godeny and Gauntt, 1987b; Godeny and Gauntt, 1986).
The complement system may play a role in CVB3-induced
myocarditis because C3, for example, is involved in
antigen retention in germinal centers and viral clearance
from spleen (Anderson et al., 1997). Furthermore, it has
been clearly shown for myosin-induced experimental
autoimmune myocarditis that the presence of complement
receptor type I and II expressed on a subset of T cells is
important for myocarditis induction (Kaya et al., 2001).
Toll-like receptors (TLRs) are important for recognition
of conserved microbial structures and subsequent
activation of innate immune responses. In CVB3
infection, both myocarditis and viral replication are
signiﬁcantly reduced in the absence of TLR4 (Fairweather
et al., 2003). The availability of knockout mice for
the several TLR types will help to further clarify the role
of the innate immune system for CVB3-induced
myocarditis.
Adaptive Immune Responses in Virus-induced
Myocarditis
The prominent role of T cells for the induction and/or
severity of myocarditis is known since the pioneering
work of Woodruff and Woodruff (1974) who showed that
T cell-depleted mice suffer less from severe CVB-
mediated myocarditis than control mice. Similarly,
athymic nude mice show reduced disease after CVB3
infection (Hashimoto and Komatsu, 1978). Gene-deﬁcient
mice have been used to further delineate the immuno-
pathological mechanisms in CVB3-induced myocarditis
(Table I). CD8-deﬁcient mice showed reduced survival
after CVB3 infection, but showed no difference in the
degree of myocarditis indicating that the contribution of
CD8 T cells in immune-mediated heart inﬂammation is
limited (Opavsky et al., 1999). Studies in mice lacking the
dominant effector molecule of cytotoxic T cells, perforin,
provided conﬂicting results concerning the contribution of
this molecule in CVB3 infection. Gebhard and colleagues
showed that perforin-knockout mice survive CVB3
infection and that infection-associated myocarditis is
less severe (Gebhard et al., 1998). However, other studies
could not detect signiﬁcant differences between wild-type
and perforin-knockout mice after CVB3 infection (Klingel
et al., 2003). The reason for these differences remains so
far elusive, but the results from both studies clearly
indicate that perforin is not essential for CVB3
elimination. An important role for T helper cells in the
development of myocarditis is indicated by the fact that
both CD4/CD8- and abTCR-deﬁcient mice show an
increased survival rate and reduced myocardial damage
after CVB3 infection (Opavsky et al., 1999). Furthermore,
CVB3 elicits only mild myocarditis in mice lacking only
the CD4 molecule (Opavsky et al., 1999). Importantly,
in this series of experiments, virus titers in the hearts of
CD8-, CD4-, C4/CD8- and TCR-ab-deﬁcient mice were
comparable inthe ﬁrstweekpost infection (Opavskyetal.,
1999)demonstratingthatthe extent ofmyocardialinjuryis
mainly determined by immunopathological mechanisms.
TABLE I Impact of gene deﬁciencies on Coxsackievirus B3-induced myocarditis
Knock-out Effect on CVB myocarditis Effect on survival Strain Reference
CD8 None Reduced A/J Opavsky et al. (1999)
CD4 Reduced None A/J Opavsky et al. (1999)
CD4/CD8 Reduced Reduced A/J Opavsky et al. (1999)
TCR a/b Reduced Reduced A/J Opavsky et al. (1999)
b2-microglobulin Increased None C57BL/6 Klingel et al. (2003)
Perforin None None C57BL/6 Klingel et al. (2003)
Perforin Reduced Increased C57BL/6 Gebhard et al. (1998)
TCR-Ja281 None None Balb/c Huber et al. (2003)
CD1d Reduced Increased Balb/c Huber et al. (2003)
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prominent role in CVB3-induced myocarditis (Huber,
2000; Huber et al., 2002). The ﬁnding that at least
a fraction of these gd T cells are CD1d-restricted
(Huber et al., 2003) will stimulate the search for
unconventional (lipid?) antigens that trigger gd TCRs in
myocarditis.
Infection of humans and mice by CVB3 as well as
MCMV infection of mice induces the production of
autoantibodies to cardiac myosin and other heart antigens
(Neu et al., 1990; O’Donoghue et al., 1990; Lauer et al.,
1994). These antibodies appear earliest on day 7 post
infection in CVB3 infected mice and can be eluted from
the heart muscle (Neumann et al., 1994; Latif et al., 1999).
The question that arises is whether these autoantibodies
play a critical role for the onset and progression of
autoimmune myocarditis. Studies on CVB3 infection in B
cell-deﬁcient mice indicated that antibodies are not
important for the development of myocarditis and disease
progression, but play a prominent role in the control of the
infection (Mena et al., 1999). However, B cells secreting
heart-speciﬁc autoantibodies may impact on immune-
mediated myocardial inﬂammation. For example, anti-
myosin antibodies can mediate myocarditis in susceptible
mouse strains and disease susceptibility depends on the
presence of myosin or a myosin-like molecule in cardiac
extracellular matrix (Liao et al., 1995). Furthermore, a
recent report revealed that DCM in the negative immune
regulatory receptor PD-1-knockout mice is mediated by
autoantibodies reactive to cardiomyocytes (Nishimura
et al., 2001). Autoantibodies recognizing extracellularly
deposited cardiac troponin I (cTn I) induced dilatation and
dysfunction of the heart by induction of a permanent
inﬂux of Ca
2þ in cardiomyocytes. Interestingly, the
presence of cTn I-speciﬁc antibodies in the heart
did not induce inﬂammation, despite the formation of
immune complexes (Okazaki et al., 2003). It is
noteworthy that in this particular experimental setting,
myocarditis is not a prerequisite for the development of
immune-mediated DCM.
Immune Mechanisms in Autoimmune Myocarditis
The best-studied cardiac autoantigen is the alpha chain of
cardiac myosin. Immunization of susceptible mice with
myosin protein or deﬁned, MHC class II restricted myosin
peptidesinducesmyocarditis(Neuetal.,1987)(seeFig.1).
This experimental approach uncouples the chronic phase
from the virus infection, and is therefore a valuable tool to
study the mechanisms and effector molecules involved in
autoimmune myocarditis and to evaluate therapeutic
strategies. As shown in adoptive transfer experiments, the
inﬂammatory response in autoimmune myocarditis is
mediated by Th cells. Transfer of CD4 T cells
from peptide-immunized mice induces myocarditis in
non-immunizedmice(SmithandAllen,1991).Inaddition,
the injection of anti-MHC II antibodies prevents disease
(Pummerer et al., 1991). Induction of autoimmune
myocarditis in mice strongly depends on the genetic
background and the MHC II locus (Neu et al., 1987).
Likewise, human chronic heart disease has also
been correlated to certain HLA alleles and experiments
in transgenic mice expressing human CD4 and
HLA-DQ6 show that genetically resistant C57BL/6 mice
may become susceptible to autoimmune myocarditis
(Bachmaier et al., 1999). Autoimmune damage in the
heart by Th cells is most likely mediated via local
interaction with professional antigen-presenting cells
(APCs) because myocytes do not express MHC II
molecules. It has been demonstrated that expression of
myosin-MHC II complexes are presented by resident heart
APC and that the presentation of this antigen precedes the
inﬁltration of T cells (Smith and Allen, 1992).
Furthermore, MHC II upregulation in the heart is a
prerequisite for disease induction as shown in tumor
necrosis factor (TNF)-Rp55-deﬁcient mice, where MHC
II upregulation is abrogated (Bachmaier et al., 1997).
Other proinﬂammotory cytokines such as IL-12 and IFN-g
have been shown to be involved in the pathogenesis of
autoimmune myocarditis. IL-12, like TNF-a, is important
for the onset of disease and IFN-g seems to play a
protective role via the induction of nitric oxide
(Afanasyeva et al., 2001; Eriksson et al., 2001a,b). As
mentioned above, complement receptors I and II
expression on a subset of T cells is important for the onset
of autoimmune myocarditis (Kaya et al., 2001).
Furthermore, it was shown that dendritic cell-
induced autoimmune myocarditis requires cooperation
between adaptive and innate immune responses (Eriksson
et al., 2003). Further studies using transgenic
mice and genetically modiﬁed viruses will help to shed
light on the complex mechanisms operative in auto-
immune myocarditis.
FIGURE 1 Immunopathogenesis of myocarditis. The inlet shows
massive mononuclear cell inﬁltration and cardiomyocyte necrosis in a
heart section of a myosin peptide-immunized Balb/c mouse (HE stain,
magniﬁcation: £ 100).
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The etiological link between infection, myocarditis and
subsequent DCM is well-established in humans. Further-
more, the shift from pathogen-induced myocarditis to an
autoimmune-mediated chronic degenerative heart disease
is well-documented in animal models. It has been
proposed that breaking of self-tolerance to autoantigens
is mediated by molecular mimicry, bystander activation or
epitope spreading (Vanderlugt and Miller, 2002).
Although the contribution of these immunopathological
mechanisms has been studied in other virus infections
such as Theiler’s virus (Vanderlugt and Miller, 2002) or
lymphocytic choriomeningitis virus (Zinkernagel, 2002),
a detailed analysis for CVB3 infection is still lacking.
The knowledge how CVB3 and maybe other infectious
agents cause myocarditis and subsequent DCM will make
these diseases amenable to new treatment options such as
immunosuppression (Frustaci et al., 2002) or immuno-
modulation (Fig. 1).
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